These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38919512)

  • 41. Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada.
    Lepik KJ; Hunt OL; Bacani N; Wang L; Harris M; Toy J; McLinden T; Sereda P; Akagi LJ; Ready E; Montaner JS; Barrios R
    Antivir Ther; 2024 Feb; 29(1):13596535241233128. PubMed ID: 38375582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Decline in HIV-1 Drug Resistance in Heavily Antiretroviral-Experienced Patients Is Associated with Optimized Prescriptions in a Treatment Roll-Out Program in Mexico.
    Calva JJ; Larrea S; Tapia-Maltos MA; Ostrosky-Frid M; Lara C; Aguilar-Salinas P; Rivera H; Ramírez JP
    AIDS Res Hum Retroviruses; 2017 Jul; 33(7):675-680. PubMed ID: 28094565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ogbuagu O; Ruane PJ; Podzamczer D; Salazar LC; Henry K; Asmuth DM; Wohl D; Gilson R; Shao Y; Ebrahimi R; Cox S; Kintu A; Carter C; Das M; Baeten JM; Brainard DM; Whitlock G; Brunetta JM; Kronborg G; Spinner CD;
    Lancet HIV; 2021 Jul; 8(7):e397-e407. PubMed ID: 34197772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV.
    Tieosapjaroen W; Chow EPF; Fairley CK; Hoy J; Aguirre I; Ong JJ
    AIDS Patient Care STDS; 2023 Mar; 37(3):131-137. PubMed ID: 36809049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir.
    Yilma D; Abdissa A; Kæstel P; Tesfaye M; Olsen MF; Girma T; Ritz C; Friis H; Andersen ÅB; Kirk O
    BMC Infect Dis; 2020 Aug; 20(1):582. PubMed ID: 32762646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.
    Kovari H; Surial B; Tarr PE; Cavassini M; Calmy A; Schmid P; Bernasconi E; Rauch A; Wandeler G; Ledergerber B;
    HIV Med; 2021 Aug; 22(7):623-628. PubMed ID: 33880839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.
    Papatheodoridis GV; Dalekos GN; Idilman R; Sypsa V; Van Boemmel F; Buti M; Calleja JL; Goulis J; Manolakopoulos S; Loglio A; Papatheodoridi M; Gatselis N; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Yurdaydin C; Esteban R; Janssen HLA; Berg T; Lampertico P
    J Hepatol; 2020 Nov; 73(5):1037-1045. PubMed ID: 32553667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
    Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K
    J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.
    Blanco JR; Caro-Murillo AM; Castaño MA; Olalla J; Domingo P; Arazo P; Gómez-Sirvent JL; Riera M; Pulido F; Vera F; Romero-Palacios A; Aguirrebengoa K; Portilla J; Ferrer P; Pedrol E
    HIV Clin Trials; 2013; 14(5):204-15. PubMed ID: 24144897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.
    Bazzoli C; Jullien V; Le Tiec C; Rey E; Mentré F; Taburet AM
    Clin Pharmacokinet; 2010; 49(1):17-45. PubMed ID: 20000887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Spaulding A; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs.
    Van Dyke RB; Chadwick EG; Hazra R; Williams PL; Seage GR
    Front Immunol; 2016; 7():199. PubMed ID: 27242802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers.
    Mogalian E; Stamm LM; Osinusi A; Brainard DM; Shen G; Ling KHJ; Mathias A
    Clin Infect Dis; 2018 Aug; 67(6):934-940. PubMed ID: 29522076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.
    Greenberg L; Ryom L; Neesgaard B; Wandeler G; Staub T; Gisinger M; Skoll M; Günthard HF; Scherrer A; Mussini C; Smith C; Johnson M; De Wit S; Necsoi C; Pradier C; Wit F; Lehmann C; d'Arminio Monforte A; Miró JM; Castagna A; Spagnuolo V; Sönnerborg A; Law M; Hutchinson J; Chkhartishvili N; Bolokadze N; Wasmuth JC; Stephan C; Vannappagari V; Rogatto F; Llibre JM; Duvivier C; Hoy J; Bloch M; Bucher HC; Calmy A; Volny Anne A; Pelchen-Matthews A; Lundgren JD; Peters L; Bansi-Matharu L; Mocroft A;
    Clin Infect Dis; 2021 Oct; 73(7):e2323-e2333. PubMed ID: 33354721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort.
    Monteiro N; Branco M; Peres S; Borges F; Mansinho K
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19565. PubMed ID: 25394072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of antiretroviral drug regimens and drug-drug interactions between younger and older HIV-infected patients at a tertiary care teaching hospital in South Korea.
    Park MS; Yang YM; Kim JS; Choi EJ
    Ther Clin Risk Manag; 2018; 14():2229-2241. PubMed ID: 30519031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of virological response to therapy and resistance profile in treatment-experienced and naive HIV-1 infected Romanian patients receiving regimens containing darunavir boosted with ritonavir or cobicistat.
    Marin RC; Streinu-Cercel A; Moleriu LC; Bungau SG
    Biomed Pharmacother; 2022 Jun; 150():113077. PubMed ID: 35658217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study.
    Leone S; Shanyinde M; Cozzi Lepri A; Lampe FC; Caramello P; Costantini A; Giacometti A; De Luca A; Cingolani A; Ceccherini Silberstein F; Puoti M; Gori A; d'Arminio Monforte A;
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):871-881. PubMed ID: 29318459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.